Eskitis collaborates with pharmaceutical companies and not for profit organisations. The aim of these partnerships is to develop new therapies for diseases common to Western countries, and also “neglected” diseases that burden developing nations.
| Organisation | Link |
|---|---|
 |
Press Release: Griffith provides hope for a new antibiotic |
 |
The natural product expertise of the Eskitis Institute has led to a new partnership between Griffith University and the Jarlmadangah Burru Aboriginal Community in Broome, Western Australia to develop novel pain-killing drugs from traditional Aboriginal medicine. |
 |
Eskitis is working closely with the Medicines for Malaria Venture to develop new drugs to fight malaria. |
 |
Eskitis is working closely with the Drugs for Neglected Diseases Initiative to develop new drugs to fight Human African Trypanosomiasis, commonly known as African Sleeping Sickness. |
 |
Griffith University is the only Queensland Node of the $148m Cancer Therapeutics CRC , which is focusing on the discovery and early development of small molecule drugs for the treatment of cancer. |